UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Journal of translational medicine, 2018-05, Vol.16 (1), p.125-125, Article 125

2018

Volltextzugriff (PDF)

Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation

PloS one, 2015-11, Vol.10 (11), p.e0141979

2015

Volltextzugriff (PDF)

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway

PloS one, 2017-11, Vol.12 (11), p.e0187294

2017

Volltextzugriff (PDF)

Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes

Chemico-biological interactions, 2016-08, Vol.255, p.31-44

2016

Volltextzugriff (PDF)

The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model

Chronobiology international, 2015-06, Vol.32 (5), p.608-614

2015

Volltextzugriff (PDF)

The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection

Cells (Basel, Switzerland), 2021-11, Vol.10 (11), p.3072

2021

Volltextzugriff (PDF)

Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work

Drug metabolism and disposition, 2022-02, Vol.50 (2), p.95-104

2022

Volltextzugriff (PDF)

Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone

Drug metabolism and disposition, 2009-07, Vol.37 (7), p.1505-1512

2009

Volltextzugriff (PDF)

Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression

Drug metabolism and disposition, 2008-05, Vol.36 (5), p.955-962

2008

Volltextzugriff (PDF)

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: Exploration of P2 quinazoline substituents

Bioorganic & medicinal chemistry letters, 2010-07, Vol.20 (14), p.4004-4011

2010

Volltextzugriff (PDF)

The Effect of Repeated Administration of Cyclophosphamide on Cytochrome P450 2B in Rats

Clinical cancer research, 2007-07, Vol.13 (14), p.4218-4224

2007

Volltextzugriff (PDF)

Flavin-containing monooxygenase 3

PloS one, 2017-11, Vol.12 (11), p.e0187294

2017

Volltextzugriff (PDF)

A strategy for early-risk predictions of clinical drug-drug interactions involving the GastroPlusTM DDI module for time-dependent CYP inhibitors

Xenobiotica, 2018-04, Vol.48 (4), p.348-356

2018

Volltextzugriff (PDF)

A strategy for early-risk predictions of clinical drug-drug interactions involving the GastroPlus TM DDI module for time-dependent CYP inhibitors

Xenobiotica, 2018-04, Vol.48 (4), p.348-356

2018

Volltextzugriff (PDF)

Confident application of a global human liver microsomal activity QSAR

Future medicinal chemistry, 2018-07, Vol.10 (13), p.1575-1588

2018

Volltextzugriff (PDF)

Gas chromatographic–mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-01, Vol.913-914 (15), p.98-105

2013

Volltextzugriff (PDF)

Busulphan Metabolism Via Flavin-Containing Monooxygenase 3 (FMO3) Can Explain Several Interactions with Other Drugs

BLOOD, 2014-12, Vol.124 (21), p.1150-1150

2014

Volltextzugriff (PDF)

Discovery and characterization of AZD9272 and AZD6538—Two novel mGluR5 negative allosteric modulators selected for clinical development

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (22), p.6974-6979

2012

Volltextzugriff (PDF)

Quantification of interactions between drug leads and serum proteins by use of “binding efficiency”

Analytical biochemistry, 2011-02, Vol.409 (2), p.163-175

2011

Volltextzugriff (PDF)

Discovery of 4′-azido-2′-deoxy-2′-C-methyl cytidine and prodrugs thereof: A potent inhibitor of Hepatitis C virus replication

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3265-3268

2012

Volltextzugriff (PDF)

The effect of repeated administration of cyclophosphamide on cytochrome P4502B in rats

Clinical cancer research, 2007-07, Vol.13 (14), p.4218

2007

Volltextzugriff (PDF)

Few alterations in clinical pathology and histopathology observed in a CYP2C18 19 humanized mice model

Acta veterinaria scandinavica, 2008-11, Vol.50 (1), p.47

2008

Volltextzugriff (PDF)

The Effect of Repeated Administration of Cyclophosphamide on CYP2B1 and 2B2 in Rat

BLOOD, 2005, Vol.106 (11), p.4460-4460

2005

Volltextzugriff (PDF)

Few alterations in clinical pathology and histopathology observed in a CYP2C18&19 humanized mice model

Acta veterinaria scandinavica, 2008-11, Vol.50 (1), p.47-47, Article 47

2008

Volltextzugriff (PDF)

Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease

Alcohol (Fayetteville, N.Y.), 1993-11, Vol.10 (6), p.447-452

1993

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Animals
(16)
Male
(14)
Humans
(13)
Pharmacology & Pharmacy
(11)
Medicin Och Hälsovetenskap
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(8)
Cytochrome P450
(7)
Liver
(7)
Rats
(7)
Cytochrome P-450 Enzyme System - Metabolism
(6)
Microsomes, Liver - Enzymology
(6)
Chemistry
(5)
Female
(5)
Metabolism
(5)
Mice
(5)
Pharmacology. Drug Treatments
(5)
Physical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway

Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes

The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model

The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection

Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work

Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone

Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: Exploration of P2 quinazoline substituents

The Effect of Repeated Administration of Cyclophosphamide on Cytochrome P450 2B in Rats

Flavin-containing monooxygenase 3

A strategy for early-risk predictions of clinical drug-drug interactions involving the GastroPlusTM DDI module for time-dependent CYP inhibitors

A strategy for early-risk predictions of clinical drug-drug interactions involving the GastroPlus TM DDI module for time-dependent CYP inhibitors

Confident application of a global human liver microsomal activity QSAR

Gas chromatographic–mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine

Busulphan Metabolism Via Flavin-Containing Monooxygenase 3 (FMO3) Can Explain Several Interactions with Other Drugs

Discovery and characterization of AZD9272 and AZD6538—Two novel mGluR5 negative allosteric modulators selected for clinical development

Quantification of interactions between drug leads and serum proteins by use of “binding efficiency”

Discovery of 4′-azido-2′-deoxy-2′-C-methyl cytidine and prodrugs thereof: A potent inhibitor of Hepatitis C virus replication

The effect of repeated administration of cyclophosphamide on cytochrome P4502B in rats

Few alterations in clinical pathology and histopathology observed in a CYP2C18 19 humanized mice model

The Effect of Repeated Administration of Cyclophosphamide on CYP2B1 and 2B2 in Rat

Few alterations in clinical pathology and histopathology observed in a CYP2C18&19 humanized mice model

Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease

Suchergebnisse filtern